Listen now | I sat down with Dr. Jay Bhattacharya, professor of medicine at Stanford University and a leading voice in public health policy, to explore the catastrophic failures of the COVID response and what they reveal about the scientific establishment and government institutions.
Faster matters a lot when you’re sick and waiting on a potential treatment, though. The economical part is also deeply tied to the speed and the FDA process. So it’s complicated.
We don't need faster drug approval, we need ECONOMICAL, SAFE drugs, THAT WORK.
Faster matters a lot when you’re sick and waiting on a potential treatment, though. The economical part is also deeply tied to the speed and the FDA process. So it’s complicated.